Get the Stockscreener App
108.14
0.86%
0.92
Boston Scientific Corp stock is traded at $108.14, with a volume of 7.45M.
It is up +0.86% in the last 24 hours and up +4.85% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$107.22
Open:
$107.455
24h Volume:
7.45M
Relative Volume:
1.08
Market Cap:
$160.24B
Revenue:
$18.49B
Net Income/Loss:
$2.50B
P/E Ratio:
64.37
EPS:
1.68
Net Cash Flow:
$3.49B
1W Performance:
+2.50%
1M Performance:
+4.85%
6M Performance:
+9.09%
1Y Performance:
+32.52%
1-Day Range:
$106.80
$108.68
1-Week Range:
$104.24
$108.68
52-Week Range:
$80.64
$108.68
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
108.14 | 158.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
ABT
Abbott Laboratories
|
132.20 | 231.38B | 43.11B | 13.94B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
393.11 | 149.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.99 | 119.16B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.21 | 47.52B | 5.69B | 1.41B | 577.90M | 6.95 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Apr-16-25 | Upgrade | Needham | Hold → Buy |
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
RSI and MACD Indicate Shift in Boston Scientific Corporation Sentiment - beatles.ru
Oppenheimer sees stronger growth at Boston Scientific - Investing.com
Boston Scientific stock rating upgraded by Oppenheimer to Outperform - Investing.com
Boston Scientific stock rating upgraded at Oppenheimer with $125 price target - Investing.com
Visual trend scoring systems applied to Boston Scientific CorporationPortfolio Performance Report & Accurate Technical Buy Alerts - Newser
Is Boston Scientific Stock Outperforming the S&P 500? - MSN
Is Boston Scientific Corporation benefiting from innovation trendsJuly 2025 Snapshot & Fast Exit and Entry Strategy Plans - خودرو بانک
What is the target price for Boston Scientific Corporation stockGap Down & Weekly High Return Stock Opportunities - خودرو بانک
Is Boston Scientific Corporation forming a reversal patternJuly 2025 PostEarnings & Risk Controlled Stock Pick Alerts - Newser
Is Boston Scientific Corporation vulnerable to short sellersJuly 2025 EndofMonth & AI Forecast Swing Trade Picks - خودرو بانک
Boston Scientific’s Peripheral Interventions president is retiring - MassDevice
Risk adjusted return profile for Boston Scientific Corporation analyzedWeekly Trend Recap & Smart Money Movement Tracker - Newser
Can volume confirm reversal in Boston Scientific CorporationPortfolio Risk Summary & Expert Curated Trade Setup Alerts - Newser
Boston Scientific Corporation (BSX) Announces Executive Retireme - GuruFocus
Boston Scientific executive Jeffrey Mirviss to retire, will serve as senior advisor By Investing.com - Investing.com South Africa
Applying Elliott Wave Theory to Boston Scientific Corporation2025 Market Overview & Real-Time Buy Signal Notifications - Newser
Why is Boston Scientific Corporation stock going upTrade Exit Report & Precise Swing Trade Alerts - خودرو بانک
Boston Scientific executive Jeffrey Mirviss to retire, will serve as senior advisor - Investing.com
October 24th Options Now Available For Boston Scientific (BSX) - Nasdaq
What makes Boston Scientific Corporation stock price move sharply2025 Winners & Losers & Long-Term Growth Stock Strategies - Newser
Insights Into the $50+ Billion Urology Care Devices & Platforms Market 2025-2030 Featuring Boston Scientific, Olympus, Medtronic, Coloplast, and BD Among Other Industry Giants - Yahoo Finance
Is Boston Scientific Corporation forming a breakout patternJuly 2025 Chart Watch & Free Safe Capital Growth Stock Tips - خودرو بانک
Is Boston Scientific Corporation a potential multi baggerJuly 2025 WrapUp & Smart Allocation Stock Tips - خودرو بانک
Fitzgerald of Boston Scientific (BSX) sells $5.2m in stock - Investing.com
The top Boston Scientific stories of 2025 so far - MassDevice
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Cryotherapy Device Market Insights Report 2025-2030 with Exclusive Data on 25 Vendors Including Boston Scientific, Cryo Innovations, MECOTEC, Medtronic, Metrum Cryoflex, and Zimmer MedizinSysteme - Yahoo Finance
What does recent volatility data suggest for Boston Scientific CorporationDividend Hike & Accurate Entry/Exit Alerts - Newser
How to monitor Boston Scientific Corporation with trend dashboardsMarket Growth Report & Reliable Price Breakout Alerts - Newser
Is Boston Scientific Corporation meeting your algorithmic filter criteriaWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Sector ETF performance correlation with Boston Scientific Corporation2025 EndofYear Setup & AI Enhanced Execution Alerts - Newser
Signal strength of Boston Scientific Corporation stock in tech scannersJuly 2025 EndofMonth & Real-Time Volume Triggers - Newser
Statistical indicators supporting Boston Scientific Corporation’s strengthTrade Analysis Report & Expert Approved Momentum Ideas - Newser
Analyzing drawdowns of Boston Scientific Corporation with statistical toolsOptions Play & High Win Rate Trade Alerts - Newser
Boston Scientific reports strong Farapulse, Watchman FLX data - MassDevice
Boston Scientific Unit Defends Heart Valve Patent From Abbott - Law360
Grand River Aseptic Manufacturing (GRAM) Appoints Denis Johnson as Chief Executive Officer - GlobeNewswire Inc.
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - Barchart.com
Can Boston Scientific Corporation navigate macro headwinds2025 EndofYear Setup & Weekly Return Optimization Plans - خودرو بانک
How high can Boston Scientific Corporation stock goStop Loss & Intraday High Probability Setup Alerts - Newser
Detecting price anomalies in Boston Scientific Corporation with AIJuly 2025 PreEarnings & Reliable Breakout Stock Forecasts - Newser
Using R and stats models for Boston Scientific Corporation forecasting2025 Analyst Calls & Real-Time Buy Zone Alerts - Newser
How sentiment analysis helps forecast Boston Scientific Corporation2025 Retail Activity & High Accuracy Trade Signal Alerts - Newser
What’s next for Boston Scientific Corporation stock priceJuly 2025 PreEarnings & Scalable Portfolio Growth Ideas - Newser
Stock Analysis | Boston Scientific OutlookA Technical Downturn Amid Mixed Analyst Signals - AInvest
Visual analytics tools that track Boston Scientific Corporation performance2025 Geopolitical Influence & Low Risk Entry Point Tips - Newser
Is a relief rally coming for Boston Scientific Corporation holdersJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
What moving averages say about Boston Scientific CorporationTrade Signal Summary & Daily Momentum Trading Reports - Newser
Does Boston Scientific Corporation show high probability of reboundJuly 2025 Highlights & Fast Entry High Yield Tips - Newser
Key resistance and support levels for Boston Scientific CorporationMarket Trend Summary & Verified Swing Trading Watchlists - Newser
Analyzing net buyer seller activity in Boston Scientific CorporationMarket Trend Review & Safe Capital Preservation Plans - Newser
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):